Murphy Peter C. 4
4 · TELA Bio, Inc. · Filed Feb 27, 2024
Insider Transaction Report
Form 4
TELA Bio, Inc.TELA
Murphy Peter C.
Chief Commercial Officer
Transactions
- Award
Common Stock
2024-02-23+13,200→ 51,547 total - Tax Payment
Common Stock
2024-02-23$7.07/sh−2,315$16,367→ 49,232 total - Tax Payment
Common Stock
2024-02-24$7.07/sh−940$6,646→ 48,292 total - Award
Stock Option (Right to Buy)
2024-02-23+19,300→ 19,300 totalExercise: $7.07Exp: 2034-02-23→ Common Stock (19,300 underlying)
Footnotes (4)
- [F1]These restricted stock units ("RSUs") will vest in four equal annual installments beginning on February 23, 2025, subject to the Reporting Person's continuous service through the applicable vesting dates.
- [F2]Includes 156 shares acquired under the Company's employee stock purchase plan on July 31, 2023 and 204 shares acquired under the Company's employee stock purchase plan on January 31, 2024.
- [F3]Shares withheld by the Issuer to satisfy applicable withholding taxes upon vesting of RSUs.
- [F4]The option vests 25% on February 23, 2025, with the remaining 75% vesting in equal monthly installments on the last day of each of the 36 calendar months immediately following such date, subject to the Reporting Person's continued service through the applicable vesting dates.